Les antirétroviraux au Botswana. Observatoire des mutations de l'intervention internationale sur la santé en Afrique

Fanny Chabrol

Revue Tiers-Monde, 2013, vol. n°215, issue 3, 17-34

Abstract: By focusing on access to free antiretroviral treatments in Botswana, this article analyses recent transformations of international cooperation on health issues. The partnership between the government of Botswana, the pharmaceutical company Merck & Co and the Bill and Melinda Gates Foundation was made possible through pre-existing biomedical collaboration between the government of Botswana and the Harvard School of Public Health. This configuration of actors and interests offers a vantage point of contemporary global health partnerships in which philanthropy, science and public health overlap. Most often determined by their convenience, accessibility and chance of success, global health interventions tend to reproduce inequalities within health systems and on a global level.

Keywords: Aids; global health; Botswana; antiretrovirals; pharmceutical philanthropy; biomedical research (search for similar items in EconPapers)
Date: 2013
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.cairn.info/load_pdf.php?ID_ARTICLE=RTM_215_0017 (application/pdf)
http://www.cairn.info/revue-tiers-monde-2013-3-page-17.htm (text/html)
free

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:cai:rtmarc:rtm_215_0017

Access Statistics for this article

More articles in Revue Tiers-Monde from Armand Colin
Bibliographic data for series maintained by Jean-Baptiste de Vathaire ().